Advances and technical standards in neurosurgery. Vol. 35, Low-Grade Gliomas
https://libcat.nshealth.ca/en/permalink/provcat29474
volume editor, J. Schramm.
--Vienna:
Springer
, c2010.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Other Authors
- Schramm, J
- Other Authors
- European Association of Neurosurgical Societies
- Responsibility
- volume editor, J. Schramm
- Place of Publication
- Vienna
- Publisher
- Springer
- Date of Publication
- c2010
- Physical Description
- 1 online resource (xiii, 256 p.)
- Series Vol.
- v. 35
- Series Title
- Advances and technical standards in neurosurgery
- ISBN
- 9783211994818
- Subjects (MeSH)
- Glioma - surgery
- Subjects (LCSH)
- Neurosurgery
- Contents
- Advances in imaging low-grade gliomas -- Molecular neuropathology of low-grade gliomas and its clinical impact -- What is the place of conservative management for adult supratentorial low-grade glioma? -- Seizures in patients with low-grade gliomas: incidence, pathogenesis, surgical management, and pharmacotherapy -- Present day’s standards in microsurgery of low-grade gliomas -- Is there a place for radiotherapy in low-grade gliomas? -- The place of interstitial brachytherapy and radiosurgery for low-grade gliomas -- Health-related quality of life aspects in patients with low-grade glioma.
- Format
- e-Book
- Location
- Online
Current Understanding and Treatment of Gliomas
https://libcat.nshealth.ca/en/permalink/provcat39134
Jeffrey Raizer, Andrew Parsa, editors.
--Cham:
Springer
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book reviews the significant advances in our understanding of glioma biology that have been achieved during the past decade and describes in detail the resultant new approaches to treatment. Improvements in surgical techniques, radiation therapy, and chemotherapy are comprehensively covered, with discussion of their impact in decreasing patient morbidity and increasing survival. In addition, individual chapters are devoted specifically to current treatment for low-grade gliomas, anaplastic…
- Available Online
- View e-Book
- Other Authors
- Raizer, Jeffrey
- Parsa, Andrew
- Responsibility
- Jeffrey Raizer, Andrew Parsa, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2015
- Physical Description
- 1 online resource (vi, 184 p. : 9 illus., 8 illus. in color)
- Series Vol.
- 163
- Series Title
- Cancer treatment and research
- ISBN
- 9783319120485
- 9783319120478 (print ed.)
- ISSN
- 0927-3042
- Subjects (MeSH)
- Glioma - therapy
- Abstract
- This book reviews the significant advances in our understanding of glioma biology that have been achieved during the past decade and describes in detail the resultant new approaches to treatment. Improvements in surgical techniques, radiation therapy, and chemotherapy are comprehensively covered, with discussion of their impact in decreasing patient morbidity and increasing survival. In addition, individual chapters are devoted specifically to current treatment for low-grade gliomas, anaplastic gliomas, and glioblastoma multiforme. Other topics addressed include treatment of the elderly patient, investigating emerging therapies from small molecules to immunotherapy and palliative care. This timely book will be a valuable source of up-to-date information for practitioners and will also be of interest to researchers.
- Contents
- Epidemiology of Gliomas -- Glioma Biology and Molecular Markers -- Surgery for Gliomas -- Radiation Therapy of Glioblastoma -- Low-Grade Glioma -- Treatment of Anaplastic Glioma -- Current Medical Treatment of Glioblastoma -- Novel Chemotherapeutic Approaches in Adult High-Grade Gliomas -- Immunotherapy for Malignant Gliomas -- Glioblastoma in the Elderly -- Palliative and Supportive Care for Glioma Patients.
- Format
- e-Book
- Location
- Online
Diffuse Low-Grade Gliomas in Adults
https://libcat.nshealth.ca/en/permalink/provcat41774
Hugues Duffau, editor.
(Second edition)
--Cham:
Springer
, 2017.
- Available Online
- View e-Book
- Location
- Online
The second edition of this well-received volume has been revised and updated to reflect the advances in pathological classification and molecular epidemiology of diffuse low-grade gliomas (DLGG) in adults and offers an updated review on individualized therapies. This book presents the latest research pertaining to the diagnosis, genetics, therapy and management of DLGGs. It extensively covers recent research on the natural history of DLGGs and their interaction with the brain and reviews the ne…
- Available Online
- View e-Book
- Other Authors
- Duffau, Hugues
- Responsibility
- Hugues Duffau, editor
- Edition
- Second edition
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- 2017
- Physical Description
- 1 online resource (x, 753 pages) : 79 illus., 66 illus. in color
- ISBN
- 9783319554662
- 9783319554648 (print ed.)
- Abstract
- The second edition of this well-received volume has been revised and updated to reflect the advances in pathological classification and molecular epidemiology of diffuse low-grade gliomas (DLGG) in adults and offers an updated review on individualized therapies. This book presents the latest research pertaining to the diagnosis, genetics, therapy and management of DLGGs. It extensively covers recent research on the natural history of DLGGs and their interaction with the brain and reviews the new diagnostic and therapeutic strategies which increase survival and quality of life of the patient. New topics covered are the management of DLGGs during pregnancy, functional rehabilitation of patients with DLGG and the onco-functional balance in DLGG, among others. The reader will have the opportunity to gain insight in both clinical and basic science aspects of this type of tumor and learn about the application of novel imaging techniques such as diffussion tensor imaging. Edited by a leading expert in the field and authored by a team of recognised specialists, this book is a valuable resource for medical oncologists, neuro-oncologists and neurologists.
- Contents
- 1. Introduction: From the Inhibition of Dogmas to the Concept of Personalized Management in Patients with Diffuse Low-Grade Gliomas -- Part I: Epidemiology and Classification -- 2. Epidemiology of Diffuse Low Grade Gliomas -- 3. Molecular Epidemiology of Diffuse Low-Grade Glioma -- 4. Molecular-Genetic Classification of Gliomas and Its Practical Application to Diagnostic Neuropathology -- 5. Towards an Intermediate Grade in Glioma Classification -- Part II: Fundamental Science -- 6. Pathogenesis of Diffuse Low-Grade Gliomas -- 7. Dissemination of Diffuse Low-Grade Gliomas: Tools and Molecular Insights -- 8. The Genomics of Diffuse Low-Grade Gliomas -- 9. Diffuse Low-Grade Glioma Associated Stem Cells -- 10. Molecular Imaging of Diffuse Low Grade Glioma -- Part III: Clinical Aspects and Diagnostic Imaging -- 11. Clinical Presentation in Diffuse Low-Grade Gliomas - 12. Epilepsy and Diffuse Low-Grade Gliomas -- 13. Quality of Life in Patients with Diffuse Low-Grade Glioma -- 14. Magnetic Resonance Oncometabolic Imaging in DLGG Beyond the Image - 15. Positron-Emission-Tomography in Diffuse Low-Grade Gliomas -- 16. Dynamics of DLGG and Clinical Implications -- 17. Natural History and Spontaneous Prognostic Factors -- Part IV: Functional Assessment and Interaction with the Brain -- 18. Language, Cognitive and Emotional Evaluations -- 19. Task-Based and Resting-State Functional MRI in DLGG -- 20. Diffusion Magnetic Resonance Imaging in Diffuse Low-Grade Gliomas -- 21. Magnetoencephalography, Functional Connectivity and Neural Network Topology in Diffuse Low-Grade Gliomas -- 22. Interactions Between Diffuse Low-Grade Glioma (DLGG), Brain Connectome and Neuroplasticity -- Part V: New Insights into the Therapeutic Strategies for DLGG -- 23. Surgery for Diffuse Low-Grade Gliomas (DLGG) Oncological Outcomes -- 24. Surgery for Diffuse Low-Grade Gliomas (DLGG) Functional Ouctomes -- 25. Chemotherapy for Diffuse Low Grade Gliomas -- 26. Radiation Therapy in the Treatment of Low Grade Gliomas -- 27. Functional Rehabilitation in Patients with DLGG -- 28. New Individualized and Dynamic Therapeutic Strategies in DLGG -- Part VI: Prospects -- 29. Emerging Therapies for Diffuse Low Grade Glioma -- 30. Pregnancy and Diffuse Low-Grade Gliomas -- 31. Biomathematical Modeling of DLGG -- 32. Resection Probability Maps of Glioma -- 33. The Concept of Onco-Functional Balance in the Management of DLGG -- 34. The Origins of Diffuse Low-Grade Gliomas -- 35. From Management of Incidental DLGG to Screening of Silent DLGG.
- Format
- e-Book
- Location
- Online
Diffuse low-grade gliomas in adults : natural history, interaction with the brain, and new individualized therapeutic strategies
https://libcat.nshealth.ca/en/permalink/provcat32544
Hugues Duffau, editor.
--London:
Springer
, c2013.
- Available Online
- View e-Book
- Location
- Online
The biology, behavior and management of diffuse low-grade gliomas (DLGG) in adults have been matters of controversy for many decades. However, recent technical and conceptual advances in genetics, imaging and treatments have paved the way towards individualized management. In addition, advancing knowledge of brain processing means that it is possible to take into consideration the interaction between the disease (low-grade glioma) and the host (the brain) and thus to modulate the therapeutic st…
- Available Online
- View e-Book
- Other Authors
- Duffau, Hugues
- Responsibility
- Hugues Duffau, editor
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2013
- Physical Description
- 1 online resource (xvii, 502 p. : 73 ill., 53 ill. in color)
- ISBN
- 9781447122135
- Subjects (MeSH)
- Glioma
- Subjects (LCSH)
- Medicine
- Radiology, Medical
- Neurology
- Oncology
- Abstract
- The biology, behavior and management of diffuse low-grade gliomas (DLGG) in adults have been matters of controversy for many decades. However, recent technical and conceptual advances in genetics, imaging and treatments have paved the way towards individualized management. In addition, advancing knowledge of brain processing means that it is possible to take into consideration the interaction between the disease (low-grade glioma) and the host (the brain) and thus to modulate the therapeutic strategies with the goal to increase the median survival as well as to improve the quality of life. Diffuse Low-Grade Gliomas in Adults: Natural History, Interaction with the Brain, and New Individualized Therapeutic Strategies presents the latest research pertaining to the diagnosis, therapy and management of diffuse low-grade gliomas (DLGG) in adults, with a particular focus on the path towards individualized therapy for this kind of tumor. Recent research on the natural history of DLGGs and their interaction with the brain has led to new diagnostic and therapeutic strategies which increase survival and quality of life of the patient, and these methods are described in this book. This book uniquely focuses on addressing diffuse low-grade gliomas in adults and is a valuable resource for medical oncologists, neuro-oncologists and neurologists.
- Contents
- 1. Introduction: From the Inhibition of Dogmas to the Concept of Personalized Management in Diffuse Low-Grade Gliomas -- 2. Epidemiology of Diffuse Low-Grade Gliomas -- 3. Histological Classification -- 4. Is Gliomatosis Cerebri a Diffuse Low-Grade Glioma? -- 5. Contribution of Molecular Biology to the classification of Low-Grade Diffuse Gliomas -- 6. Cellular origin of Grade II Gliomas -- 7. Deciphering the Molecular and Cellular Basis for Dissemination of Diffuse Low-Grade Gliomas -- 8. The molecular biology of Diffuse Low-Grade Gliomas -- 9. Proteomic Studies in Low-Grade Gliomas: What They Have Informed About Pathophysiology? -- 10. Human Low-Grade Glioma Cultures -- 11. Animal Models for Low-Grade Gliomas -- 12. Clinical Presentation in Diffuse Low-Grade Gliomas -- 13. Epilepsy in Diffuse Low-Grade Gliomas -- 14. Quality of Life in Low-Grade Gliomas -- 15. Metabolic-Oncological MR Imaging of Diffuse Low-Grade Glioma: A Dynamic Approach -- 16. Positron-Emission Tomography in Diffuse Low-Grade Gliomas -- 17. Dynamics of Diffuse Low-Grade Gliomas and Clinical Implications -- 18. Natural History and Spontaneous Prognostic Factors -- 19. Language and Other Cognitive Evaluations -- 20. Functional MR and Diffusion MR Imaging in Diffuse Low-Grade Gliomas -- 21. Magnetoencephalography, Functional Connectivity and Neural Network Topology in Diffuse Low-Grade Gliomas -- 22. Interactions Between Diffuse Low-Grade Glioma and Brain Plasticity -- 23. Surgery for Diffuse Low-Grade Gliomas: Oncological Considerations -- 24. Surgery for Diffuse Low-Grade Gliomas: Functional Considerations -- 25. Chemotherapy for Diffuse Low-Grade Gliomas -- 26. Radiation Therapy for the Treatment of Diffuse Low-Grade Gliomas -- 27. New Individualized Strategies in Diffuse Low-Grade Gliomas -- 28. Biomathematical Modeling of Diffuse Low-Grade Glioma Behavior -- 29. Towards the Definition of New Endpoints -- 30. Functional Rehabilitation in Patients with Diffuse Low-Grade Glioma -- 31. Early Detection and Management of Incidental Diffuse Low-Grade Gliomas (IDLGG): Towards a "Prophylactic Oncological Neurosurgery" -- 32. The Origins of Diffuse Low-Grade Gliomas: "Functional Theory" Versus "Molecular Theory".
- Format
- e-Book
- Location
- Online
Emerging concepts in neuro-oncology
https://libcat.nshealth.ca/en/permalink/provcat32284
Colin Watts, editor.
--London:
Springer
, c2013.
- Available Online
- View e-Book
- Location
- Online
Neuro-oncology is one of the most exciting and rapidly evolving areas of oncology. In recent years there has been a remarkable increase in activity in the field, from basic science through to the clinic. This is reflected by advances in the understanding of the biology of CNS malignancies which have informed the development of novel and successful therapies. In this environment it is essential to facilitate communication and understanding of new ideas and concepts. Emerging Concepts in Neuro-O…
- Available Online
- View e-Book
- Other Authors
- Watts, Colin
- Responsibility
- Colin Watts, editor
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2013
- Physical Description
- 1 online resource (x, 220 p. : 54 ill., 50 ill. in color)
- ISBN
- 9780857294586
- Subjects (MeSH)
- Brain neoplasms
- Glioma
- Medical Oncology - trends
- Subjects (LCSH)
- Oncology
- Neurosciences
- Neurology
- Abstract
- Neuro-oncology is one of the most exciting and rapidly evolving areas of oncology. In recent years there has been a remarkable increase in activity in the field, from basic science through to the clinic. This is reflected by advances in the understanding of the biology of CNS malignancies which have informed the development of novel and successful therapies. In this environment it is essential to facilitate communication and understanding of new ideas and concepts. Emerging Concepts in Neuro-Oncology is written with this in mind: to encourage collaboration across traditional boundaries and promote translational research for patient benefit. The book moves from concepts in the scientific basis of neuro-oncology in part one, through models of brain cancer in part two, to emerging concepts in clinical practice in part three, with a focus on translational research. This book will be an essential read for neuroscience researchers, cancer researchers, neurosurgeons and clinical oncologists as well as anyone with an interest in this exciting, dynamic field.
- Contents
- 1. Classification of Gliomas -- 2. Epigenetics and Brain Cancer -- 3. Astrocyte Differentiation from Oligodendrocyte Precursors -- 4. Stem Cells and Brain Cancer -- 5. In Vitro Models of Brain Cancer -- 6. Mouse Models of Glioma Pathogenesis: History and State of the Art -- 7. The Application of Novel Ionising Radiation Species for Glioblastoma -- 8. Advances in Imaging Brain Cancer -- 9. Surgical Management of Glial Cancers -- 10. Radiation Oncology in Brain Cancer -- 11. Managing the Elderly Patient -- 12. Brain Tumour Presentation in Children and Young People -- 13. How Can We Improve Clinical Trial Recruitment in Neuro-Oncology? -- Index.
- Format
- e-Book
- Location
- Online
Glioma Imaging : Physiologic, Metabolic, and Molecular Approaches
https://libcat.nshealth.ca/en/permalink/provcat45019
Whitney B. Pope, editor.
--Cham:
Springer
, c2020.
- Available Online
- View e-Book
- Location
- Online
This book covers physiologic, metabolic and molecular imaging for gliomas. Gliomas are the most common primary brain tumors. Imaging is critical for glioma management because of its ability to noninvasively define the anatomic location and extent of disease. While conventional MRI is used to guide current treatments, multiple studies suggest molecular features of gliomas may be identified with noninvasive imaging, including physiologic MRI and amino acid positron emission tomography (PET). Thes…
- Available Online
- View e-Book
- Other Authors
- Pope, Whitney B.
- Responsibility
- Whitney B. Pope, editor
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2020
- Physical Description
- 1 online resource (xiv, 286 p.) : 109 illus., 69 illus. in color
- ISBN
- 9783030273590
- 9783030273583 (Print ed.)
- 9783030273606 (Print ed.)
- 9783030273613 (Print ed.)
- Subjects (MeSH)
- Glioma - diagnostic imaging
- Neuroimaging - methods
- Specialty
- Diagnostic Imaging
- Medical Oncology
- Abstract
- This book covers physiologic, metabolic and molecular imaging for gliomas. Gliomas are the most common primary brain tumors. Imaging is critical for glioma management because of its ability to noninvasively define the anatomic location and extent of disease. While conventional MRI is used to guide current treatments, multiple studies suggest molecular features of gliomas may be identified with noninvasive imaging, including physiologic MRI and amino acid positron emission tomography (PET). These advanced imaging techniques have the promise to help elucidate underlying tumor biology and provide important information that could be integrated into routine clinical practice. The text outlines current clinical practice including common scenarios in which imaging interpretation impacts patient management. Gaps in knowledge and potential areas of advancement based on the application of more experimental imaging techniques will be discussed. In reviewing this book, readers will learn: current standard imaging methodologies used in clinical practice for patients undergoing treatment for glioma and the implications of emerging treatment modalities including immunotherapy the theoretical basis for advanced imaging techniques including diffusion and perfusion MRI, MR spectroscopy, CEST and amino acid PET the relationship between imaging and molecular/genomic glioma features incorporated in the WHO 2016 classification update and the potential application of machine learning about the recently adopted and FDA approved standard brain tumor protocol for multicenter drug trials of the gaps in knowledge that impede optimal patient management and the cutting edge imaging techniques that could address these deficits.
- Contents
- 1. Indications and Limitations of Conventional Imaging: Current Clinical Practice in the Context of Standard Therapy -- 2. Surrogates for Disease Status: Contrast Enhancement Including Limitations of Pseudoprogression and Pseudoresponse -- 3. The Relationship Between Biological and Imaging Characteristics in Enhancing and Nonenhancing Glioma -- 4. Contrast-Enhanced T1-Weighted Digital Subtraction for Increased Lesion Conspicuity and Quantifying Treatment Response in Malignant Gliomas -- 5. Advanced Physiologic Imaging: Perfusion. Theory and Applications -- 6. Advanced Physiologic Imaging: Diffusion. Theory and Applications -- 7. Parametric Response Map (PRM) Analysis Improves Response Assessment in Gliomas -- 8. Review of WHO 2016 Changes to Classification of Gliomas. Incorporation of Molecular Markers -- 9. Imaging Markers of Low Grade Diffuse Glioma -- 10. CEST, pH and Glucose Imaging as Markers for Hypoxia and Malignant Transformation -- 11. MRS for D-2HG Detection in IDH Mutant Glioma -- 12. C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors -- 13. FET and FDOPA PET Imaging in Glioma -- 14. Imaging Genomics -- 15. Radiomics and Machine Learning -- 16. Immunotherapy and Gliomas -- 17. The Path Forward –The Standardized Brain Tumor Imaging Protocol (BTIP) for Multicenter Trials.
- Format
- e-Book
- Location
- Online
edited by Andreas Deimling.
--Berlin, Heidelberg:
Springer
, c2009.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Deimling, Andreas
- Responsibility
- edited by Andreas Deimling
- Place of Publication
- Berlin, Heidelberg
- Publisher
- Springer
- Date of Publication
- c2009
- Series Vol.
- 171
- Series Title
- Recent results in cancer research
- ISBN
- 9783540312062
- Subjects (MeSH)
- Glioma - diagnosis
- Glioma - therapy
- Format
- e-Book
- Location
- Online
High-grade gliomas : diagnosis and treatment
https://libcat.nshealth.ca/en/permalink/provcat22484
Barnett, Gene H.
--Totowa, NJ:
Humana Press
, 2007.
- Call Number
- QZ 380 H638 2007
- Location
- Dickson Building
- Call Number
- QZ 380 H638 2007
- Author
- Barnett, Gene H
- Place of Publication
- Totowa, NJ
- Publisher
- Humana Press
- Date of Publication
- 2007
- Physical Description
- 495 p. + 1 CD-ROM
- Series Title
- Current clinical oncology
- ISBN
- 1588295117
- Subjects (MeSH)
- Glioma - diagnosis
- Glioma - therapy
- Format
- Book
- Location
- Dickson Building
- Loan Period
- 3 weeks
High-Grade Gliomas : Diagnosis and Treatment
https://libcat.nshealth.ca/en/permalink/provcat28107
edited by Gene H. Barnett.
--Totowa, NJ:
Humana Press
, c2007.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Barnett, Gene H
- Responsibility
- edited by Gene H. Barnett
- Place of Publication
- Totowa, NJ
- Publisher
- Humana Press
- Date of Publication
- c2007
- Series Title
- Current clinical oncology
- ISBN
- 9781597451857
- Subjects (MeSH)
- Glioma - diagnosis
- Glioma - therapy
- Therapies, Investigational
- Format
- e-Book
- Location
- Online
Imaging Gliomas After Treatment : A Case-based Atlas
https://libcat.nshealth.ca/en/permalink/provcat44814
Tommaso Scarabino, Saverio Pollice, editors.
(Second edition)
--Cham:
Springer
, c2020.
- Available Online
- View e-Book
- Location
- Online
This book illustrates the characteristics of imaging after treatment in brain gliomas. It describes in detail the modifications to brain tissue, both healthy and pathological, that can manifest after surgery, radiotherapy or chemotherapy treatment. These modifications are discussed in terms of both how they occur in the immediate post-treatment period, and in the long term. The imaging methods used include CT with and without the addition of contrast medium, but above all MRI, which involves th…
- Available Online
- View e-Book
- Other Authors
- Scarabino, Tommaso
- Pollice, Saverio
- Responsibility
- Tommaso Scarabino, Saverio Pollice, editors
- Edition
- Second edition
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2020
- Physical Description
- 1 online resource (xii, 279 p.) : 213 illus., 84 illus. in color
- ISBN
- 9783030312107
- 9783030312091 (Print ed.)
- 9783030312114 (Print ed.)
- 9783030312121 (Print ed.)
- Subjects (MeSH)
- Brain Neoplasms - therapy
- Glioma - therapy
- Magnetic Resonance Imaging
- Neuroimaging
- Treatment Outcome
- Specialty
- Diagnostic Imaging
- Medical Oncology
- Abstract
- This book illustrates the characteristics of imaging after treatment in brain gliomas. It describes in detail the modifications to brain tissue, both healthy and pathological, that can manifest after surgery, radiotherapy or chemotherapy treatment. These modifications are discussed in terms of both how they occur in the immediate post-treatment period, and in the long term. The imaging methods used include CT with and without the addition of contrast medium, but above all MRI, which involves the use of routine basic sequences and mainly advanced study techniques such as diffusion, perfusion, spectroscopy and cortical activation. The aim of the text is to equip neuroradiologists with adequate expertise in post-treatment examinations reporting, allowing them to perform an effective differential diagnosis between the persistency or recurrence of illness and the effects of short or long-term treatment. The book is divided into a general section, which addresses the classification of cerebral tumors, the surgical treatment options, radiotherapy and chemotherapy protocols, and a section on clinical cases that employs rich iconography, making it quick and easy to consult. This second edition has been updated to reflect the new WHO classification system from 2016, new surgical, radiotherapy and chemotherapeutic treatment options, and (in the iconography section) the new sequences available from the manufacturers of RM scanners.
- Contents
- Part I. Introduction -- Brain Tumors -- Part II. Treatment of Gliomas -- Surgery -- Radiation therapy -- Chemotherapy and Future Developments -- Part III. Post Treatment Neuroradiologic Imaging -- Magnetic Resonance Techniques -- Post-surgical MR Morfologic Imaging -- Postradiation Changes in Morphologic MRI -- Postchemotherapy Morphological MR Imaging -- PET Imaging -- Advanced MR Imaging -- Part IV. Clinical Cases.
- Format
- e-Book
- Publication Type
- Atlas
- Case Reports
- Location
- Online
Imaging gliomas after treatment : a case-based atlas
https://libcat.nshealth.ca/en/permalink/provcat31232
Tommaso Scarabino editor, in collaboration with Ferdinando Caranci ... [et al.], editors.
--Milan:
Springer
, c2012.
- Available Online
- View e-Book
- Location
- Online
Patients with gliomas frequently undergo combination therapy that can result in complex and potentially confusing appearances on follow-up imaging. In this context, differentiation between tumor recurrence and radiation necrosis, for example, can be very difficult. This atlas is a detailed guide to the imaging appearances of gliomas following treatment with neurosurgery, radiation therapy, and chemotherapy. Normal and pathological findings are displayed in detailed MR images that illustrate the…
- Available Online
- View e-Book
- Other Authors
- Scarabino, Tommaso
- Responsibility
- Tommaso Scarabino editor, in collaboration with Ferdinando Caranci ... [et al.], editors
- Place of Publication
- Milan
- Publisher
- Springer
- Date of Publication
- c2012
- Physical Description
- 1 online resource (216 p. : 600 ill., 50 ill. in color)
- ISBN
- 9788847023703
- Subjects (MeSH)
- Brain Neoplasms - therapy - Case Reports
- Glioma - therapy - Case Reports
- Magnetic Resonance Imaging - Atlases
- Neuroimaging - Atlases
- Subjects (LCSH)
- Radiology, Medical
- Radiotherapy
- Neurology
- Neurosurgery
- Oncology
- Abstract
- Patients with gliomas frequently undergo combination therapy that can result in complex and potentially confusing appearances on follow-up imaging. In this context, differentiation between tumor recurrence and radiation necrosis, for example, can be very difficult. This atlas is a detailed guide to the imaging appearances of gliomas following treatment with neurosurgery, radiation therapy, and chemotherapy. Normal and pathological findings are displayed in detailed MR images that illustrate the potential modifications due to treatment. Particular emphasis is placed on characteristic appearances on the newer functional MR imaging techniques, including MR spectroscopy, diffusion-weighted imaging, and perfusion imaging. These techniques are revolutionizing neuroradiology by going beyond the demonstration of macroscopic alterations to the depiction of preceding metabolic changes at the cellular and subcellular level. They thereby improve the accuracy, sensitivity, and specificity of MR imaging and allow earlier and more specific diagnosis. A key section comprising some 40 clinical cases and more than 500 illustrations offers an invaluable clinical and research tool not only for neuroradiologists but also for neurosurgeons, radiotherapists, and medical oncologists.
- Contents
- Part A. Introduction -- 1. Brain Tumors -- Part B. Treatment of Gliomas -- 2. Surgery -- 3. Radiation Therapy -- 4. Chemotherapy -- 5. Future Developments -- Part C. Post-treatment Neuroradiologic Imaging -- 6. Magnetic Resonance Techniques -- 7. Postsurgical Morphologic MR Imaging -- 8. Post Radiation-therapy Morphologic MR Imaging -- 9. Post Chemotherapy Morphologic MR Imaging -- 10. Advanced MR Imaging -- Part D. Clinical Cases -- Case 1. Early Sequelae. Postoperative CT Scan in Glioblastoma Multiforme -- Case 2. Early and Late Sequelae: Evolution of Postsurgical Area. Postoperative MR Follow-up in Glioblastoma Multiforme -- Case 3. Late Sequelae: Gliotic Scar Formation. Postoperative MR Follow-up in Grade II Oligoastrocytoma -- Case 4. Early Complications: Epidural Hematoma. Postoperative CT in Pilocytic Astrocytoma -- Case 5. Early Complications: Perilesional Ischemia. Postoperative MR Follow-up in Glioblastoma Multiforme -- Case 6. Late Complications: Subdural Empyema. CT/MR Follow-up in Glioblastoma Multiforme -- Case 7. Late Complications: Abscess. Postoperative MR Follow-up in Glioblastoma Multiforme -- Case 8. Early Residual Tumor. Postoperative MR Follow-up in Glioblastoma Multiforme -- Case 9. Late Residual Tumor. Postoperative MR Follow-up in Low-grade Astrocytoma -- Case 10. Low-grade Residual Tumor. Morphofunctional MR Follow-up in Anaplastic Oligoastrocytoma -- Case 11. Medium-low-grade Residual Tumor. Morphofunctional MR Follow-up in Astrocytoma -- Case 12. Medium-low-grade Residual Tumor. Morphofunctional MR Follow-up in Fibrillar Astrocytoma -- Case 13. Medium-low-grade Residual Tumor. Morphofunctional MR Follow-up in Anaplastic Oligodendroglioma -- Case 14. High-grade Residual Tumor. Morphofunctional MR Follow-up in Gemistocytic Astrocytoma -- Case 15. High-grade Residual Tumor. Morphofunctional MR Follow-up in Low-grade Oligoastrocytoma and Following Anaplastic Transformation -- Case 16. Stable Disease. Multimodal CT/MR Follow-up in Glioblastoma Multiforme -- Case 17. Stable Disease. Morphofunctional MR Follow-up in Glioblastoma Multiforme -- Case 18. Stable Disease. 3T Multimodal MR Follow-up in Glioblastoma Multiforme -- Case 19. Stable Disease. 3T Morphofunctional MR Follow-up in High-grade Oligodendroglioma -- Case 20 Tumor Recurrence. Postoperative MR Follow-up in Grade II Oligodendroglioma -- Case 21. Tumor Recurrence. Postoperative MR Follow-up in Gliosarcoma -- Case 22. Tumor Recurrence. Postoperative MR Follow-up in Low-grade Astrocytoma -- Case 23. Tumor Recurrence. Postoperative MR Follow-up in Anaplastic Oligoastrocytoma -- Case 24. Tumor Progression/Recurrence. Multimodal CT/MR Follow-up in Glioblastoma Multiforme -- Case 25. Tumor Progression/Recurrence. Multimodal CT/MR Follow-up in Anaplastic Astrocytoma -- Case 26. Tumor Progression/Recurrence. Multimodal CT/MR Follow-up in Glioblastoma Multiforme -- Case 27. Local and Distant Recurrence. 3T Multimodal MR Follow-up in Glioblastoma Multiforme -- Case 28 Tumor Recurrence. 3T Morphofunctional MR Follow-up in Low-grade Astrocytoma with Anaplastic Appearance -- Case 29 Tumor Progression. Morphofunctional MR Follow-up in Glioblastoma Multiforme -- Case 30. Tumor Progression. Morphofunctional MR Follow-up in Glioblastoma Multiforme -- Case 31. Tumor Progression. Morphofunctional MR Follow-up in Glioblastoma Multiforme -- Case 32. Radionecrosis. MR Follow-up in Metastasis from Breast Cancer -- Case 33 Radionecrosis. Morphofunctional MR Follow-up in Metastasis from Breast Cancer -- Case 34. Radionecrosis. Morphofunctional MR Follow-up in Glioblastoma -- Case 35. Late Radionecrosis. CT/MR Performed in Nasopharyngeal Carcinoma -- Case 36. Late Radionecrosis. CT/MR Follow-up in Nasopharyngeal Carcinoma -- Case 37. Late Radionecrosis. Postoperative and Post-radiation Therapy Follow-up in Meningioma -- Case 38 Radionecrosis. 3T Multimodal MR Follow-up in Anaplastic Astrocytoma -- Case 39. Radiation-induced eukoencephalopathy. MR Follow-up After Whole Brain Radiation Therapy -- Case 40 Radiation Therapy-induced Tumor Pseudoprogression. MR Follow-up in Pilocytic Astrocytoma -- Case 41. Chemotherapy-induced Tumor Pseudoprogression. 3T MR Follow-up in Glioblastoma -- Case 42. Chemotherapy-induced Tumor Pseudoprogression with Disease Progression. 3T Morphofunctional MR Follow-up in Anaplastic Astrocytoma -- Case 43. Drug-induced Leukoencephalopathy. MR Follow-up After Corticosteroid Therapy -- Case 44. Drug-induced Leukoencephalopathy. MR Follow-up After Methotrexate Therapy -- Case 45 Drug-induced Thrombosis. MR Follow-up After L-asparaginase Therapy -- Case 46. PRES (Posterior Reversible Encephalopathy Syndrome). MR Follow-up After Cyclosporine Therapy -- Case 47. PRES (Posterior Reversible Encephalopathy Syndrome). MR Follow-up After Cisplatin Therapy -- Case 48. Morphofunctional MR in the Diagnosis and Follow-up of Cerebral Gliomas.
- Format
- e-Book
- Location
- Online
Management of Adult Glioma in Nursing Practice
https://libcat.nshealth.ca/en/permalink/provcat44054
Ingela Oberg, editor.
--Cham:
Springer
, 2019.
- Available Online
- View e-Book
- Location
- Online
This contributed book focuses on the nursing care and considerations for the most common type of malignant brain tumours – gliomas, out of the 150 different types of brain tumours. The reader will gain specialist knowledge in understanding the disease trajectory of malignant gliomas and gain a deeper understanding of the presenting symptoms and varying treatment options of this highly malignant tumour. High grade malignant gliomas impact significantly on prognosis, with an average life expectan…
- Available Online
- View e-Book
- Other Authors
- Oberg, Ingela
- Responsibility
- Ingela Oberg, editor
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- 2019
- Physical Description
- 1 online resource (xii, 314 p.) : 35 illus., 25 illus. in color
- ISBN
- 9783319767475
- 9783319767468 (Print ed.)
- 9783319767482 (Print ed.)
- Subjects (MeSH)
- Adult
- Glioma - nursing
- Oncology Nursing - methods
- Specialty
- Medical Oncology
- Neurology
- Nursing
- Abstract
- This contributed book focuses on the nursing care and considerations for the most common type of malignant brain tumours – gliomas, out of the 150 different types of brain tumours. The reader will gain specialist knowledge in understanding the disease trajectory of malignant gliomas and gain a deeper understanding of the presenting symptoms and varying treatment options of this highly malignant tumour. High grade malignant gliomas impact significantly on prognosis, with an average life expectancy of 18-24 months from diagnosis, given maximum treatment options including surgery, chemotherapy and radiotherapy. This book takes you through all current treatment options with their associated risks and intended benefits. Brain tumours affect not just the patient, but their family and carers too and this important aspect of holistic nursing care is not to be overlooked. This book encompasses first hand experiences of both a brain tumour patient living with a glioma and aspects from a carer. The structure of this book follows a typical patient pathway from presenting signs/symptoms through to MDT (multidisciplinary team) discussions to surgical techniques and radiological investigations, right through to chemotherapy, radiotherapy and palliative care including end of life care. It provides a distinct overview of the holistic needs spectrum encompassing the entire patient journey and equips the reader with learning objectives set at every chapter. Although this book is primarily aimed at Nurses working at ward level within neuro-oncology, this book is also intended to benefit professionals new to the field of specialist nursing – in particular those working with adult brain tumours and neuro-oncology.
- Contents
- 1. Neuroanatomy and Physiology -- 2. Neuroimaging -- 3. Neurological Assessment of Patients with Gliomas -- 4. Multidisciplinary Team Working -- 5. Medical Management of Adult Glioma -- 6. Glioma Surgery -- 7. The Classification of Adult Gliomas -- 8. Pre- and Post-operative Complications -- 9. Neurorehabilitation -- 10. A Voyage Around My Brain and Myself -- 11. Holistic Needs Assessment and Care Planning -- 12. Communication Skills: The Patient as Co-pilot -- 13. The Mental Capacity Act/Deprivation of Liberty Safeguards and Their Relationship to Adult Safeguarding -- 14. Radiotherapy -- 15. Chemotherapy for Gliomas -- 16. Allied Health Professional Rehabilitation in the UK -- 17. Teenagers and Young Adults/Transition Services: Implications for Nurses -- 18. Carers Perspective: “The Wind, It Howls” -- 19. End of Life Care for the Glioma Patient.
- Format
- e-Book
- Location
- Online
Neuropathology
https://libcat.nshealth.ca/en/permalink/provcat32161
edited by Richard A. Prayson.
(2nd ed.)
--Philadelphia, PA:
Elsevier Saunders
, c2012.
- Available Online
- View e-Book
- Access
- Registration required for PDF access.
- Location
- Online
- Available Online
- View e-Book
- Other Authors
- Prayson, Richard A
- Responsibility
- edited by Richard A. Prayson
- Edition
- 2nd ed.
- Place of Publication
- Philadelphia, PA
- Publisher
- Elsevier Saunders
- Date of Publication
- c2012
- Physical Description
- 1 online resource (xv, 630 p.)
- Series Title
- Foundations in diagnostic pathology
- ISBN
- 9781455728282 (electronic bk.)
- 9781437709490
- Subjects (MeSH)
- Nervous System Diseases - pathology
- Glioma - pathology
- Subjects (LCSH)
- Nervous system - Diseases
- Nervous system - Diseases - Diagnosis
- Nervous System Diseases - pathology
- Glioma - pathology
- Contents
- Overview of central nervous system anatomy and histology / Daniel J. Brat -- Vascular disease / Anthony T. Yachnis -- Trauma / David Dolinak -- Congenital malformations, perinatal diseases, and phacomatoses / Rebecca D. Folkerth, Hart G.W. Lidov -- Dysmyelinating and demyelinating disorders / B.K. Kleinschmidt-DeMasters, Jack H. Simon -- Neurodegenerative diseases / Elizabeth J. Cochran -- Infections / Kymberly A. Gyure -- Metabolic and toxic disorders / Dimitri P. Agamanolis -- Glial and glioneuronal tumors / Arie Perry, Richard A. Prayson -- Non-glial tumors / Richard A. Prayson -- Skeletal muscle and peripheral nerve / J. Douglas Miles, Mark L. Cohen.
- Access
- Registration required for PDF access.
- Format
- e-Book
- Location
- Online
Neuropathology : a volume in the foundations in diagnostic pathology series
https://libcat.nshealth.ca/en/permalink/provcat51020
Prayson, Richard.
(2nd ed.)
--Philadelphia, PA:
Elsevier
, 2012.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Prayson, Richard
- Edition
- 2nd ed.
- Place of Publication
- Philadelphia, PA
- Publisher
- Elsevier
- Date of Publication
- 2012
- Series Title
- Foundations in diagnostic pathology
- ISBN
- 9781437709490
- Subjects (MeSH)
- Nervous System Diseases - pathology
- Glioma - pathology
- Notes
- Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
- Format
- e-Book
- Location
- Online
Primary Central Nervous System Tumors : Pathogenesis and Therapy
https://libcat.nshealth.ca/en/permalink/provcat29541
edited by Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen.
--Totowa, NJ:
Springer Science+Business Media
, c2011.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Norden, Andrew D
- Other Authors
- Reardon, David A
- Wen, Patrick C. Y
- Responsibility
- edited by Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen
- Place of Publication
- Totowa, NJ
- Publisher
- Springer Science+Business Media
- Date of Publication
- c2011
- Series Title
- Current clinical oncology
- ISBN
- 9781607611660
- Subjects (MeSH)
- Central Nervous System Neoplasms - etiology
- Central Nervous System Neoplasms - therapy
- Glioma - therapy
- Format
- e-Book
- Location
- Online
Tumors of the Central Nervous System. Vol. 1, Gliomas, Glioblastoma (Part 1)
https://libcat.nshealth.ca/en/permalink/provcat40903
edited by M. A. Hayat.
--Dordrecht:
Springer
, c2011.
- Available Online
- View e-Book
- Location
- Online
The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical …
- Available Online
- View e-Book
- Other Authors
- Hayat, M. A
- Responsibility
- edited by M. A. Hayat
- Place of Publication
- Dordrecht
- Publisher
- Springer
- Date of Publication
- c2011
- Physical Description
- 1 online resource (xxi, 434 p.)
- Series Vol.
- v. 1
- Series Title
- Tumors of the central nervous system
- ISBN
- 9789400703445
- 9789400703438 (print ed.)
- Subjects (MeSH)
- Antineoplastic Agents - therapeutic use
- Biomarkers
- Brain neoplasms - diagnosis
- Brain neoplasms - therapy
- Glioblastoma - diagnosis
- Glioblastoma - therapy
- Glioma - diagnosis
- Glioma - therapy
- Abstract
- The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.
- Contents
- Part I. Introduction -- 1. Introduction -- 2. Molecular Classification of Gliomas -- Part II. Biomarkers and Diagnosis -- 3. Glioblastoma: Endosialin Marker for Pericytes -- 4. Glioma Grading Using Cerebral Blood Volume Heterogeneity -- 5. The Role of Ectonucleotidases in Glioma Cell Proliferation -- 6. Gliomas: Role of Monoamine Oxidase B in Diagnosis -- 7. Glioma: Role of Integrin in Pathogenesis and Therapy -- 8. Proton Magnetic Resonance Spectroscopy in Intracranial Gliomas -- 9. Infiltration Zone in Glioma: Proton Magnetic Resonance Spectroscopic Imaging -- 10. Malignant Gliomas: Role of E2F1 Transcription Factor -- 11. The Role of Glucose Transporter-1 (GLUT-1) in Malignant Gliomas -- 12. Malignant Gliomas: Role of Platelet-Derived Growth Factor Receptor A (PDGFRA) -- 13. Molecular Methods for Detection of Tumor Markers in Glioblastomas -- 14. Role of MGMT in Glioblastomas -- 15. Glioblastomas: Role of CXCL12 Chemokine -- 16. Cell Death Signaling in Glioblastoma Multiforme: Role of the Bcl2L12 Oncoprotein -- 17. Glioblastoma Multiforme: Role of Polycomb Group Proteins -- 18. Glioblastoma Multiforme: Role of Cell Cycle-Related Kinase Protein (Method) -- Part III. Neural Stem Cells and Cancer Stem Cells -- 19. Markers of Stem Cells in Gliomas -- 20. Efficient Derivation and Propagation of Glioblastoma Stem-Like Cells Under Serum-Free Conditions Using the Cambridge Protocol -- 21. Glioma Cell Lines: Role of Cancer Stem Cells -- 22. Glioblastoma Cancer Stem Cells: Response to Epidermal Growth Factor Receptor Kinase Inhibitors -- Part IV. Therapy -- 23. Low- and High-Grade Gliomas: Extensive Surgical Resection -- 24. Brainstem Gangliogliomas: Total Resection and Close Follow-Up -- 25. Glioblastoma: Temozolomide-Based Chemotherapy -- 26. Drug-Resistant Glioma: Treatment with Imatinib Mesylate and Chlorimipramine -- 27. Glioblastoma Multiforme: Molecular Basis of Resistance to Erlotinib -- 28. Enhanced Glioma Chemosensitivity -- 29 Malignant Glioma Patients: Anti-Vascular Endothelial Growth Factor Monoclonal Antibody, Bevacizumab -- 30. Aggravating Endoplasmic Reticulum Stress by Combined Application of Bortezomib and Celecoxib as a Novel Therapeutic Strategy for Glioblastoma -- 31. Targeted Therapy for Malignant Gliomas -- 32. Glioblastomas: HER1/EGFR-Targeted Therapeutics -- 33. Epidermal Growth Factor Receptor Inhibition as a Therapeutic Strategy for Glioblastoma Multiforme -- 34. Role of Acyl-CoA Synthetases in Glioma Cell Survival and Its Therapeutic Implication -- 35. Malignant Glioma Patients: Combined Treatment with Radiation and Fotemustine -- 36. Malignant Glioma Immunotherapy: A Peptide Vaccine from Bench to Bedside -- 37. Malignant Glioma: Chemovirotherapy -- 38. Intracranial Glioma: Delivery of an Oncolytic Adenovirus -- 39. Use of Magnetic Resonance Spectroscopy Imaging (MRSI) in the Treatment Planning of Gliomas -- 40. Malignant Glioma Cells: Role of Trail-Induced Apoptosis -- Part V. Prognosis -- 41. Long-Term Survivors of Glioblastoma -- 42. Glioblastoma Patients: p15 Methylation as a Prognostic Factor.
- Format
- e-Book
- Location
- Online
Tumors of the Central Nervous System. Vol. 2, Gliomas, Glioblastoma (Part 2)
https://libcat.nshealth.ca/en/permalink/provcat40904
edited by M.A. Hayat.
--Dordrecht:
Springer
, c2011.
- Available Online
- View e-Book
- Location
- Online
Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in gene…
- Available Online
- View e-Book
- Other Authors
- Hayat, M.A
- Responsibility
- edited by M.A. Hayat
- Place of Publication
- Dordrecht
- Publisher
- Springer
- Date of Publication
- c2011
- Physical Description
- 1 online resource (xxi, 458 p.)
- Series Vol.
- v. 2
- Series Title
- Tumors of the central nervous system
- ISBN
- 9789400706187
- 9789400706170 (print ed.)
- Subjects (MeSH)
- Antineoplastic Agents - therapeutic use
- Biomarkers
- Brain neoplasms - diagnosis
- Brain neoplasms - therapy
- Glioblastoma - diagnosis
- Glioblastoma - therapy
- Glioma - diagnosis
- Glioma - therapy
- Abstract
- Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained.
- Contents
- 1. Introduction -- Part I. Biomarkers and Diagnosis -- 2. Gliomagenesis: Advantages and Limitations of Biomarkers -- 3. Molecular Subtypes of Gliomas -- 4. Glioblastoma: Germline Mutation of TP53 -- 5. Familial Gliomas: Role of TP53 Gene -- 6. The Role of IDH1 and IDH2 Mutations in Malignant Gliomas -- 7. Malignant Glioma: Isocitrate Dehydrogenases 1 and 2 Mutations -- 8. Metabolic Differences in Different Regions of Glioma Samples -- 9. Glioblastoma Patients: Role of Methylated MGMT -- 10. Brain Tumor Angiogenesis and Glioma Grading: Role of Tumor Blood Volume and Permeability Estimates Using Perfusion CT -- 11. Vasculogenic Mimicry in Glioma -- 12. Newly Diagnosed Glioma: Diagnosis Using Positron Emission Tomography with Methionine and Fluorothymidine -- 13. Role of Diffusion Tensor Imaging in Differentiation of Glioblastomas from Solitary Brain Metastases -- 14. 131I-TM-601 SPECT imaging of Human Glioma -- 15. Assessment of Biological Target Volume Using Positron Emission Tomography in High-Grade Glioma Patients -- 16. Skin Metastases of Glioblastoma -- Part II. Therapy -- 17. Diffuse Low-Grade Gliomas: What Does “Complete Resection” Mean? -- 18. Quantitative Approach of the Natural Course of Diffuse Low-Grade Gliomas -- 19. Impact of Extent of Resection on Outcomes in Patients with High-Grade Gliomas -- 20. Glioma Surgery: Intraoperative Low Field Magnetic Resonance Imaging -- 21. Low-Grade Gliomas: Intraoperative Electrical Stimulations -- 22. Malignant Gliomas: Present and Future Therapeutic Drugs -- 23. Recurrent Malignant Glioma Patients: Treatment with Conformal Radiotherapy and Systemic Therapy -- 24 Glioblastoma: Boron Neutron Capture Therapy -- 25. Glioblastoma: Anti-tumor Action of Cyclosporin A and Functionally Related Drugs -- 26. Glioblastoma Patients: Chemotherapy with Cisplatin, Temozolomide and Thalidomide -- 27. Glioblastoma: Role of Galectin-1 in Chemoresistance -- 28. Glioma-Initiating Cells: Interferon Treatment -- 29. Glioblastoma: Anti-tumor Action of Natural and Synthetic Cannabinoids -- 30. Patients with Recurrent High-Grade Glioma: Therapy with Combination of Bevacizumab and Irinotecan --- 31. Monitoring Gliomas In Vivo Using Diffusion-Weighted MRI During Gene Therapy-Induced Apoptosis -- 32. High-Grade Gliomas: Dendritic Cell Therapy -- 33. Glioblastoma Multiforme: Use of Adenoviral Vectors -- 34. Fischer/F98 Glioma Model: Methodology -- 35. Cellular and Molecular Characterization of Anti-VEGF and IL-6 Therapy in Experimental Glioma -- 36. Adult Brainstem Gliomas: Diagnosis and Treatment -- 37. The Use of Low Molecular Weight Heparin in the Treatment and Prevention of Thromboembolic Disease in Glioma Patients -- Part III. Prognosis -- 38. Brainstem Gliomas: An Overview -- 39. Tumor-Associated Epilepsy in Patients with Glioma -- 40. Brain Tumors Arising in the Setting of Chronic Epilepsy -- 41. Low-Grade Gliomas: Role of Relative Cerebral Blood Volume in Malignant Transformation -- 42. Angiocentric Glioma-Induced Seizures: Lesionectomy.
- Format
- e-Book
- Location
- Online
Tumors of the Central Nervous System. Volume 14, Glioma, Meningioma, Neuroblastoma, and Spinal Tumors
https://libcat.nshealth.ca/en/permalink/provcat39538
M.A. Hayat, editor.
(1st ed.)
--Dordrecht:
Springer Netherlands
, c2015.
- Available Online
- View e-Book
- Location
- Online
This fourteenth volume of the series provides comprehensive, current information on the diagnosis, therapy and prognosis of brain tumors and spinal tumors. For the readers' convenience, contributions are organized into three categories of Pineal Tumors, Pituitary Tumors, and Spinal Tumors. Readers will find discussion of various aspects of a number of tumor types, including angiocentric glioma, pilomyxoid astrocytoma, pituicytoma, pediatric low-grade gliomas, meningiomas and spinal cord tumors.…
- Available Online
- View e-Book
- Other Authors
- Hayat, M.A
- Responsibility
- M.A. Hayat, editor
- Edition
- 1st ed.
- Alternate Title
- Glioma, Meningioma, Neuroblastoma, and Spinal Tumors
- Place of Publication
- Dordrecht
- Publisher
- Springer Netherlands
- Date of Publication
- c2015
- Physical Description
- 1 online resource (xxxviii, 98 p. : 14 illus., 9 illus. in color)
- Series Vol.
- v. 14
- Series Title
- Tumors of the central nervous system
- ISBN
- 9789401772242
- 9789401772235 (print ed.)
- ISSN
- 2215-096X
- Subjects (MeSH)
- Central Nervous System Neoplasms
- Glioma
- Meningeal Neoplasms
- Meningioma
- Neuroblastoma
- Spinal Neoplasms
- Abstract
- This fourteenth volume of the series provides comprehensive, current information on the diagnosis, therapy and prognosis of brain tumors and spinal tumors. For the readers' convenience, contributions are organized into three categories of Pineal Tumors, Pituitary Tumors, and Spinal Tumors. Readers will find discussion of various aspects of a number of tumor types, including angiocentric glioma, pilomyxoid astrocytoma, pituicytoma, pediatric low-grade gliomas, meningiomas and spinal cord tumors. Expert oncologists, neurosurgeons, physicians, research scientists and pathologists from around the world have contributed to this extensive publication. Their chapters highlight practical experience and provide exceptional insight into the nature of cancer. The authors cover topics ranging from the use of molecular criteria in diagnosis and targeting of medicine, through evidence-based approaches, to in-depth discussion of long-term follow-up after surgery. This handbook, as earlier volumes in the series, will appeal to professionals involved in the treatment of cancer, as well as to researchers. The series crosses subjects of diagnosis, drug development, therapy and its assessment and prognosis of tumors of the central nervous system, cancer recurrence and resistance to chemotherapy.
- Contents
- 1. Angiocentric Glioma, Pilomyxoid Astrocytoma, and Pituicytoma: New Entities in the World Health Organization Classification -- 2. Pediatric Low-Grade Gliomas: Diagnosis, Treatment, and Future Directions -- 3. Kringle 1-5 Reduces Growth of Malignant Gliomas in Rats -- 4. Fluorescence Guided Resection and Photodynamic Therapy in Meningiomas -- 5. Classification of Meningiomas in the Cerebellopontine Angle -- 6. Postoperative Cerebral Hyperemia: Pathophysiology and Clinical Concerns -- 7. Evidence-Based Approach for the Management of Cerebral Metastases From Lung Adenocarcinoma -- 8. Intramedullary Spinal Cord Tumors: Long-Term Follow-up After Surgery.
- Format
- e-Book
- Location
- Online
